You searched for "regulation"
Esme’s Umbrella announces the world’s first Charles Bonnet Syndrome Essay Prizes
Esme’s Umbrella (www.charlesbonnetsyndrome) has just announced the world’s first Charles Bonnet Syndrome Essay Prizes.Lancet Commission calls for global action on blindness
The Lancet Global Health Commission on Global Eye Health highlights the changing nature of the issues facing eye health professionals worldwide.An unusual case of silicone oil in the anterior chamber simulating intraocular implant
Silicone oil internal tamponade has been used for over 50 years, even prior to pars plana vitrectomy [1].Over a course of time silicone oil may migrate to the anterior chamber through the pupil. This may disperse in the form of...
Intravitreal aflibercept for retinal angiomatous proliferation (RAP)
In this prospective study the authors present the visual and anatomical outcome of patients with RAP lesions who were treated with intravitreal aflibercept. The study cohort of 46 patients reached study completion at week 96. They were all Caucasians, with...
Microvasculature changes of mCNV after ranibizumab treatment using OCTA
In this study the authors aim to evaluate the vascular changes of myopic choroidal neovascularisation (mCNV) after ranibizumab treatment using optical coherence tomography-angiography (OCTA). The 3×3 OCTA en face images were analysed for the absence / presence of mCNV, CNV...
Rebound phenomenon after IVT triamcinolone acetonide for macular oedema
In this retrospective study, the authors report the rebound phenomenon after intravitreal triamcinolone acetonide (IVTA) injection for macular oedema secondary to diabetic retinopathy (DR) and central (CRVO) or branch retinal vein occlusion (BRVO). The incidence of a rebound phenomenon was...Researchers pursue personalised pathways for glaucoma care
Researchers, funded by Glaucoma UK in partnership with The Royal College of Ophthalmologists, are investigating the potential for personalised glaucoma care by mapping clinical trial data and real-word outcomes to individuals.
